Keyword: Bristol-Myers Squibb (BMS)


BMS to Invest $400 Million in Expansion of Dublin Site

01.03.2024 -

Bristol Myers Squibb (BMS) wants to invest $400 million for the construction and design of a sterile drug product (SDP) facility at its Cruiserath campus in Dublin...


Bristol Myers Squibb Acquires RayzeBio

28.12.2023 -

Bristol Myers Squibb will acquire RayzeBio for a total equity value of approximately $4.1 billion, or $3.6 billion net of estimated cash acquired. The transaction was...


Bristol Myers Squibb Takes Over Karuna Therapeutics

23.12.2023 -

Bristol Myers Squibb (BMS) and Karuna Therapeutics have entered into a definitive merger agreement under which the US drug maker has agreed to acquire the Boston-based...


Bristol-Myers Squibb to Acquire Mirati for up to $5.8 Billion

09.10.2023 -

Bristol-Myers Squibb (BMS) announced that it will acquire Mirati Therapeutics for up to $5.8 billion. BMS is to pay $58.00 per share in cash, for a total equity value of...

Markets & Companies

Delivering Quality with Speed for European Market

20.03.2023 -

In this interview, Jinling Chen, head of WuXi STA’s drug product business, and Jamie Andrews, site head of WuXi STA’s Couvet facility, explain the company’s strategy and...


Lotte Outlines Plans to Become Major CDMO Player

13.02.2023 -

Lotte Biologics, part of South Korean conglomerate Lotte, has detailed expansions plans for the business as it embarks on a path to become a top 10 CDMO by 2030.


BMS Sues Astra Zeneca in Cancer Drug Patent Row

21.03.2022 -

Bristol-Myers Squibb (BMS) is suing AstraZeneca Pharmaceuticals, alleging that the Anglo-Swedish drugmaker’ Imfinzi to treat lung and bladder cancer infringes several...


WuXi STA Closes Purchase of Swiss BMS plant

11.08.2021 -

WuXi STA, CDMO subsidiary of WuXi AppTec, has completed the acquisition of a drug product manufacturing facility in Couvet, Switzerland, from US pharma Bristol Myers...